52nd International Conference on Biomedical and Cancer Research
  • Follow

SciTech Biomed-Cancer 2024

52nd International Conference on Biomedical and Cancer Research 

Hirosaki University Tokyo Office, Tokyo, Japan

July 22-24, 2024

Register Now

52nd International Conference on Biomedical and Cancer Research

SciTech Biomed-Cancer 2024
is an annual event scheduled during July 22-24, 2024 at Hirosaki University Tokyo Office, Japan. Hosting researchers, scientists, students, workshop & symposium organizers, industrialists, companies, exhibitors, sponsors, media partners, oral  & poster presenters from all over the world.

Biomedical research serves as the cornerstone of modern healthcare, encompassing a broad spectrum of scientific disciplines dedicated to understanding the intricacies of the human body and combating diseases that afflict it. At its core, biomedical research seeks to decipher the underlying mechanisms of health and illness, spanning from the molecular and cellular levels to whole-body systems. Through innovative approaches such as genomics, proteomics, bioinformatics, and medical imaging, researchers delve into the complexities of human biology, unraveling the mysteries of disease onset, progression, and treatment response.

Cancer research is a dynamic and multidisciplinary field focused on understanding the complexities of cancer biology and developing effective strategies for prevention, diagnosis, and treatment. With cancer representing one of the leading causes of mortality worldwide, researchers tirelessly investigate the genetic, environmental, and lifestyle factors contributing to its onset and progression. Through cutting-edge technologies such as genomics, proteomics, and high-resolution imaging, scientists delve deep into the molecular intricacies of cancer, uncovering novel therapeutic targets and biomarkers. Furthermore, advancements in immunotherapy, targeted therapy, and precision medicine have revolutionized cancer treatment paradigms, offering new hope for patients. Cancer research not only drives scientific innovation but also embodies a relentless pursuit towards alleviating the burden of cancer and improving the quality of life for those affected by the disease.

Discussions on :
  • Advances in genomics and personalized medicine
  • Stem cell research and regenerative medicine
  • Bioinformatics and computational biology
  • Drug discovery and pharmacology
  • Biomaterials and tissue engineering
  • Respiratory diseases and pulmonary medicine
  • Endocrinology and hormone research
  • Reproductive health and fertility studies
  • Aging and gerontology research
  • Environmental health and toxicology
  • Biochemistry and molecular biology
  • Cell signaling and molecular pathways
  • Epigenetics and gene regulation
  • Imaging techniques in biomedical research
  • Cancer biology and oncology
  • Diabetes research and management
  • Precision medicine and biomarker discovery
  • Health disparities and social determinants of health
  • Public health policy and health economics
  • Clinical trials and regulatory affairs
  • Artificial intelligence in healthcare
  • Synthetic biology and genetic engineering
  • Environmental toxicology and pollution control
  • Oncogenes and tumor suppressor genes
  • Angiogenesis and cancer metastasis
  • Cancer immunotherapy
  • Targeted therapies in cancer treatment
  • Precision oncology
  • Biomarkers for cancer diagnosis and prognosis
  • Liquid biopsies for cancer detection
  • Epigenetics in cancer development
  • Role of inflammation in cancer
  • Cancer genomics and transcriptomics
  • Immunogenomics in cancer immunotherapy
  • Radiation therapy and its mechanisms of action
  • Chemotherapy and drug resistance in cancer
  • Radioimmunotherapy for cancer treatment
  • Immunomodulatory agents in cancer therapy
  • Cancer vaccines and their development
  • Liquid biopsy for monitoring treatment response
  • Circulating tumor cells and their significance
  • Computational modeling of cancer progression
  • Cancer disparities and healthcare access
  • Survivorship and quality of life in cancer patients
  • Palliative care and end-of-life issues
  • Cancer epidemiology and population studies
  • Environmental carcinogens and cancer prevention
  • Pediatric oncology and childhood cancer research
  • Geriatric oncology and cancer in the elderly
  • Rare cancers and orphan drug development
  • Artificial intelligence for early cancer detection
  • Patient-reported outcomes in cancer research
  • Cancer survivorship and long-term effects of treatment.


Accepted Abstracts

Associated Journals


Abstract due date: July 05, 2024

Early Bird closes: July 12, 2024.


Register your interest to keep up to date with the latest information.